| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO &President | See Remarks
2 companies
Brumm Joshua T is a CEO &President at Dyne Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $16.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2022 | DYN Dyne Therapeutics, Inc. | See Remarks | Sale+OE | 210,000 | $12.52 | $2,629,522.00 | -33.9% | -9.3% | -28.8% | |
| Mar 11, 2022 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 3,384 | $8.73 | $29,542.32 | -1.6% | -38.6% | +49.8% | |
| Sep 21, 2021 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 8,009 | $15.90 | $127,312.49 | -3.8% | -23.9% | -16.3% |